Sang-Yoon Lee
Chief Executive Officer bei INTEKPLUS CO., LTD.
Vermögen: 24 Mio $ am 31.03.2024
Profil
Sang-Yoon Lee is currently the CEO, Director, and Head of Research & Development at INTEKPLUS Co., Ltd.
He is also a Director at Absology Co., Ltd.
and Intekmedi Co. Ltd.
Mr. Lee has an undergraduate and graduate degree from Seoul National University and a graduate degree from Korea Advanced Institute of Science & Technology.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INTEKPLUS CO., LTD.
6,81% | 28.02.2024 | 874 678 ( 6,81% ) | 24 Mio $ | 31.03.2024 |
Aktive Positionen von Sang-Yoon Lee
| Unternehmen | Position | Beginn |
|---|---|---|
| INTEKPLUS CO., LTD. | Chief Executive Officer | - |
| Intekmedi Co. Ltd. | Director/Board Member | - |
Absology Co., Ltd.
 Absology Co., Ltd. Medical SpecialtiesHealth Technology Absology Co., Ltd. manufactures in-vitro diagnostic medical devices. The company is based in Anyang-si, South Korea. The South Korean company was founded in 2017. The CEO is Han-Sang Cho. | Director/Board Member | - |
Ausbildung von Sang-Yoon Lee
| Seoul National University | Graduate Degree |
| Korea Advanced Institute of Science & Technology | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INTEKPLUS CO., LTD. | Electronic Technology |
| Private Unternehmen | 2 |
|---|---|
Absology Co., Ltd.
Absology Co., Ltd. Medical SpecialtiesHealth Technology Absology Co., Ltd. manufactures in-vitro diagnostic medical devices. The company is based in Anyang-si, South Korea. The South Korean company was founded in 2017. The CEO is Han-Sang Cho. | Health Technology |
| Intekmedi Co. Ltd. |
